Dowe need another heart failure biomarker: focus on soluble suppression of tumorigenicity 2 (sST2)

被引：24
|
作者：
Maisel, Alan S. [1 ,2 ]
Di Somma, Salvatore [3 ]
机构：
[1] San Diego Vet Affairs Med Ctr, Div Cardiol, Vamc 3350 La Jolla Village Dr, San Diego, CA 92161 USA
[2] Univ Calif San Diego, Vamc 3350 La Jolla Village Dr, San Diego, CA 92161 USA
[3] Sapienza Univ, Sch Med & Psychol, Emergency Med St Andrea Hosp, Dept Med Surg Sci & Translat Med, Rome, Italy
来源：
EUROPEAN HEART JOURNAL | 2017年 / 38卷 / 30期
关键词：
NATRIURETIC PEPTIDE LEVELS; FAMILY-MEMBER ST2; EMERGENCY DIAGNOSIS; PROGNOSTIC VALUE; TROPONIN; THERAPY; PROCALCITONIN; GALECTIN-3; MORTALITY; PROTEIN;
D O I：
10.1093/eurheartj/ehw462
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：2325 / 2332A
页数：9
相关论文
共 50 条
  • [21] sST2 and mortality in acute heart failure
    Pauwels, Ruben
    Vandekerckhove, Hans
    De Puydt, Hendrik
    ACTA CARDIOLOGICA, 2019, 74 : 29 - 29
  • [22] Prognostic Value of sST2 in Heart Failure
    Sciatti, Edoardo
    Merlo, Anna
    Scangiuzzi, Claudio
    Limonta, Raul
    Gori, Mauro
    D'Elia, Emilia
    Aimo, Alberto
    Vergaro, Giuseppe
    Emdin, Michele
    Senni, Michele
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (12)
  • [23] Diagnostic Value of Soluble Suppression of Tumorigenicity-2 for Heart Failure
    Huang, Dong-Hui
    Sun, Hao
    Shi, Jing-Pu
    CHINESE MEDICAL JOURNAL, 2016, 129 (05) : 570 - 577
  • [24] Diagnostic Value of Soluble Suppression of Tumorigenicity-2 for Heart Failure
    Huang Dong-Hui
    Sun Hao
    Shi Jing-Pu
    中华医学杂志英文版, 2016, 129 (05) : 570 - 577
  • [25] Value of increased soluble suppressor tumorigenicity biomarker 2 (sST2) on admission as an indicator of severity in patients with COVID-19
    Arnaldos-Carrillo, Maria
    Noguera-Velasco, Jose Antonio
    Martinez-Ardil, Isabel M.
    Riquelme-Perez, Alejandro
    Cebreiros-Lopez, Iria
    Hernandez-Vicente, Alvaro
    Ros-Lucas, Jose Antonio
    Khan, Amjad
    Bayes-Genis, Antoni
    Pascual-Figal, Domingo
    MEDICINA CLINICA, 2023, 161 (05): : 185 - 191
  • [26] THE PROGNOSTIC ROLE OF SOLUBLE SUPPRESSION OF TUMORIGENICITY 2 (SST2) AMONG OLDER ADULTS: ATHEROSCLEROSIS RISK IN COMMUNITIES (ARIC) STUDY
    Agha, Ali
    Hussain, Aliza
    Shah, Amil
    Hoogeveen, Ron
    Sun, Carol
    Virani, Salim
    Nambi, Vijay
    Yu, Bing
    Selvin, Elizabeth
    Matsushita, Kunihiro
    Buckley, Leo
    Chen, Lin
    Dorbala, Pranav
    Ballantyne, Christie
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2021, 77 (18) : 1658 - 1658
  • [27] Soluble suppression of tumorigenicity-2 for risk stratification in outpatients with heart failure
    Oncel, Can Ramazan
    ANATOLIAN JOURNAL OF CARDIOLOGY, 2018, 19 (03): : 228 - 228
  • [28] Elevated Plasma Concentrations Of Soluble Suppressor Of Tumorigenicity-2 (sst2) Accurately Discriminates Acute Respiratory Distress Syndrome From Acute Heart Failure
    Levy, S. D.
    Thompson, B. T.
    Matthay, M. A.
    Januzzi, J. L.
    Christiani, D. C.
    Bajwa, E.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195
  • [29] Plasma Levels of Soluble Suppression of Tumorigenicity-2 (sST2) Are Associated with Markers of Injury, Severity of Illness, and Outcomes in Mechanically Ventilated Patients with Acute Respiratory Failure
    Labar, A. S.
    Bain, W.
    Shah, F. A.
    Evankovich, J.
    Schaefer, C.
    Drohan, C. M.
    Kaufman, B. A.
    Redding, K. M.
    Finkelman, M.
    Qin, S.
    Wang, X.
    Zhang, Y.
    Nouraie, S.
    Lee, J.
    Morris, A.
    Mcverry, B. J.
    Kitsios, G.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2022, 205
  • [30] Diverging Concentrations of Soluble Suppression of Tumorigenicity (sST2) Analyzed by two Different Assay - a Limitation for its use in Clinical Practice?
    Mirna, Moritz
    Paar, Vera
    Gharibeh, Sarah
    Topf, Albert
    Hoppe, Uta C.
    Lichtenauer, Michael
    CLINICAL LABORATORY, 2023, 69 (07) : 1443 - 1450
12345